LB 1 - Prophase labs
Alternative Names: LB1 - Prophase labs; Linebacker-1Latest Information Update: 08 Jul 2024
At a glance
- Originator Global BioLife.; GRDG Sciences
- Developer ProPhase Labs
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 07 May 2024 Preclinical trials in Cancer in USA (Prophase Labs 10-k, May 2024)